Management|Prof. Dr. Philipp Beckhove, Director

The RCI is led by Executive Director Prof. Philipp Beckhove, who since 2015 is the Chair for Interventional Immunology at RCI. As tumor immunologist and internist, a particular focus of his scientific work is the translation of basic immunological research into new therapeutic strategies for oncology. The close connection of Prof. Beckhove to the University Hospital Regensburg will ensure the development of clinical trials for novel immunotherapy approaches at RCI.

Education and Degrees

  • 2009 Specialist in Internal Medicine
  • 2005 Habilitation in „Cell Biology“ at the Faculty of Biosciences of the University of Heidelberg
  • 1999 Doctorate in Medicine (M.D.) with Great Honor (Magna cum Laude), University of Heidelberg
  • 1997 Full approbation as medical doctor
  • 1988 - 1995 Studies of Medicine, Universities of Hamburg and Heidelberg
  • 1988 General High School matriculation standard

Scientific Profile

  • seit 2015 Chair for Internventional Immunology and Director of Regensburg Center for Interventional Immunology, University Regensburg
  • 2011 - 2015 Acting head of the Department of Translational Immunology at DKFZ
  • seit 2009 Adjunct Associate Professor, Northwestern University, Chicago Ill., U.S.A
  • 2008 Head of independent DKFZ Unit „Translational Immunology“
  • 2006 - 2008 Head of the independent DKFZ-junior group „T cell Tumor Immunity” at the DKFZ (after a competitive international review process)
  • 2001 - 2006 Head of the group „Cellular Immunotherapy“ at the Department of Cellular Immunology at the DKFZ
  • 1999 - 2001 Post Doc at the Department of Cellular Immunology at the German Cancer Research Center (DKFZ), Heidelberg